Cibenzoline

Independent reference data for Cibenzoline (CAS 53267-01-9), compiled from public chemistry databases.

Registry identifiers across databases

Computed descriptors

Documented uses on record

Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade.C01B - Antiarrhythmics, class i and iii

Synonyms and trade names

Cibenzoline; 53267-01-9; Cifenline; 2-(2,2-diphenylcyclopropyl)-4,5-dihydro-1H-imidazole; Cibenzolinum; Cibenzolina; Ro 22-7796; 2-(2,2-diphenylcyclopropyl)-2-imidazoline; Z7489237QT; DTXSID9022819; RO-22-7796; RefChem:126085; DTXCID702819; C01BG07; 258-453-7; Cifenline [USAN]

GHS hazard classification

Reported hazard statements	H302 (100%), H315 (100%)

H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]

H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]

What the public record says

Cibenzoline · CAS 53267-01-9 · C18H18N2. UNII Z7489237QT.

Source: PubChem / Wikidata; the batch COA governs where values differ.